For decades, the pharmaceutical industry has grappled with the inherent inefficiencies of drug discovery, a process often likened to searching…
Read More
Ginkgo, Tangible and Inductive Bio aim to move ADME decisions from lead optimization to hit ID
A significant paradigm shift is underway in the pharmaceutical industry’s approach to small-molecule drug discovery, as a new collaborative platform,…
Read More
Ginkgo, Tangible and Inductive Bio aim to move ADME decisions from lead optimization to hit ID
A new collaborative platform, ADME-One, has been launched by Ginkgo Datapoints, Tangible Scientific, and Inductive Bio, signaling a significant shift…
Read More
Baptists and Bootleggers: The Hidden Coalition Behind ‘Data-Driven’ Decisions
In the contemporary corporate landscape, the assertion of being "data-driven" has become a powerful declaration, often serving as the ultimate…
Read More
